{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:23:59Z","timestamp":1788456239131,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23713-5","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T23:34:33Z","timestamp":1763076873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of tumor protein p53 expression levels in different stages of breast cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Daniyal","family":"Arab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haniyeh Bashi Zadeh","family":"Fakhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Rouhollah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Esmaiel","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Jalalian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parnian Sadat","family":"Shahidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"8","key":"23713_CR1","first-page":"1564","volume":"50","author":"M Alizadeh","year":"2021","unstructured":"Alizadeh, M. et al. Age at diagnosis of breast cancer in iran: A systematic review and Meta-Analysis. Iran. J. public. Health. 50 (8), 1564\u20131576 (2021).","journal-title":"Iran. J. public. Health"},{"key":"23713_CR2","doi-asserted-by":"publisher","first-page":"993397","DOI":"10.3389\/fonc.2022.993397","volume":"12","author":"F Shafie","year":"2022","unstructured":"Shafie, F. et al. Breast cancer and dietary fat quality indices in Iranian women: A case-control study. Front. Oncol. 12, 993397 (2022).","journal-title":"Front. Oncol."},{"key":"23713_CR3","first-page":"61","volume":"36","author":"N Dabbagh","year":"2022","unstructured":"Dabbagh, N. et al. The effect of neoadjuvant vs adjuvant chemotherapy on final outcome of patients with triple negative breast cancer. Med. J. Islam Repub. Iran. 36, 61 (2022).","journal-title":"Med. J. Islam Repub. Iran."},{"issue":"3","key":"23713_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5306\/wjco.v5.i3.283","volume":"5","author":"R Shah","year":"2014","unstructured":"Shah, R., Rosso, K. & Nathanson, S. D. Pathogenesis, prevention, diagnosis and treatment of breast cancer. World J. Clin. Oncol. 5 (3), 283\u2013298 (2014).","journal-title":"World J. Clin. Oncol."},{"issue":"2","key":"23713_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","volume":"5","author":"Y Feng","year":"2018","unstructured":"Feng, Y. et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 5 (2), 77\u2013106 (2018).","journal-title":"Genes Dis."},{"issue":"30","key":"23713_CR6","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.2174\/1381612824666180926095709","volume":"24","author":"RP Kaur","year":"2018","unstructured":"Kaur, R. P., Vasudeva, K., Kumar, R. & Munshi, A. Role of p53 gene in breast cancer: focus on mutation spectrum and therapeutic strategies. Curr. Pharm. Des. 24 (30), 3566\u20133575 (2018).","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"23713_CR7","first-page":"105","volume":"9","author":"H Salmani","year":"2018","unstructured":"Salmani, H., Hosseini, A., Azarnezhad, A. & Ahmad, H. PTEN and p53 gene expressions in breast cancer specimens and their clinicopathological significance. Middle East. J. Cancer. 9 (2), 105\u2013111 (2018).","journal-title":"Middle East. J. Cancer"},{"issue":"2","key":"23713_CR8","first-page":"96","volume":"63","author":"FS Al-Joudi","year":"2008","unstructured":"Al-Joudi, F. S., Iskandar, Z. A. & Rusli, J. The expression of p53 in invasive ductal carcinoma of the breast: a study in the North-East States of Malaysia. Med. J. Malay. 63 (2), 96\u201399 (2008).","journal-title":"Med. J. Malay."},{"key":"23713_CR9","doi-asserted-by":"crossref","unstructured":"Vogiatzi, F. et al. Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5. Proceedings of the National Academy of Sciences. ;113(52):E8433-E42. (2016).","DOI":"10.1073\/pnas.1612711114"},{"issue":"2","key":"23713_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","volume":"22","author":"O Hassin","year":"2023","unstructured":"Hassin, O. & Oren, M. Drugging p53 in cancer: one protein, many targets. Nat. Rev. Drug Discov. 22 (2), 127\u2013144 (2023).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"11","key":"23713_CR11","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41419-022-05408-1","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell. Death Dis. 13 (11), 974 (2022).","journal-title":"Cell. Death Dis."},{"key":"23713_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-025-02383-9","author":"FN Kareem","year":"2025","unstructured":"Kareem, F. N., Fakhar, H. B., Akbari, M. E., Rasool Kashkol, I. A. A. & Rahimifar, S. Unveiling diagnostic significance: exploring miR-21, IL-12, and INF-\u03b3 in various breast cancer stages and grades. Indian J. Surg. Oncol. https:\/\/doi.org\/10.1007\/s13193-025-02383-9 (2025).","journal-title":"Indian J. Surg. Oncol."},{"key":"23713_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semcancer.2020.07.005","volume":"79","author":"MJ Duffy","year":"2022","unstructured":"Duffy, M. J., Synnott, N. C., O\u2019Grady, S. & Crown, J. Targeting p53 for the treatment of cancer. Semin Cancer Biol. 79, 58\u201367 (2022).","journal-title":"Semin Cancer Biol."},{"key":"23713_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/OTT.S342292","volume":"15","author":"TP Berke","year":"2022","unstructured":"Berke, T. P., Slight, S. H. & Hyder, S. M. Role of reactivating mutant p53 protein in suppressing growth and metastasis of Triple-Negative breast cancer. Onco Targets Ther. 15, 23\u201330 (2022).","journal-title":"Onco Targets Ther."},{"key":"23713_CR15","doi-asserted-by":"publisher","first-page":"154539","DOI":"10.1016\/j.prp.2023.154539","volume":"247","author":"N Shomali","year":"2023","unstructured":"Shomali, N. et al. Dysregulation of P53 in breast cancer: causative factors and treatment strategies. Pathol. Res. Pract. 247, 154539 (2023).","journal-title":"Pathol. Res. Pract."},{"issue":"1\u20132","key":"23713_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2007.06.010","volume":"385","author":"W Ruan","year":"2007","unstructured":"Ruan, W. & Lai, M. Actin, a reliable marker of internal control? Clin. Chim. Acta. 385 (1\u20132), 1\u20135. https:\/\/doi.org\/10.1016\/j.cca.2007.06.010 (2007).","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"23713_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/joim.20106","volume":"298","author":"P Baliakas","year":"2025","unstructured":"Baliakas, P. & Soussi, T. The TP53 tumor suppressor gene: from molecular biology to clinical investigations. J. Intern. Med. 298 (2), 78\u201396 (2025).","journal-title":"J. Intern. Med."},{"issue":"4","key":"23713_CR18","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.7150\/thno.81847","volume":"13","author":"C Marvalim","year":"2023","unstructured":"Marvalim, C., Datta, A. & Lee, S. C. Role of p53 in breast cancer progression: an insight into p53 targeted therapy. Theranostics 13 (4), 1421\u20131442 (2023).","journal-title":"Theranostics"},{"issue":"4","key":"23713_CR19","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1016\/j.modpat.2023.100100","volume":"36","author":"S Mueller","year":"2023","unstructured":"Mueller, S. et al. p53 expression in luminal breast cancer correlates with TP53 mutation and primary endocrine resistance. Mod. Pathol. 36 (4), 100100 (2023).","journal-title":"Mod. Pathol."},{"key":"23713_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3892\/ijo.2025.5758","volume":"66","author":"E Kim","year":"2025","unstructured":"Kim, E. Molecular targets and therapies associated with poor prognosis of triple-negative breast cancer (Review). Int. J. Oncol. 66, 52 (2025).","journal-title":"Int. J. Oncol."},{"key":"23713_CR21","doi-asserted-by":"publisher","first-page":"e2400767","DOI":"10.1200\/PO-24-00767","volume":"9","author":"TA Zwimpfer","year":"2025","unstructured":"ZwimpferTA et al. TP53 mutations and phosphatidylinositol 3-Kinase\/AKT pathway alterations are key determinants of breast cancer outcome independent of subtype and stage. JCO Precis Oncol. 9, e2400767 (2025).","journal-title":"JCO Precis Oncol."},{"issue":"5","key":"23713_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00428-018-2301-9","volume":"472","author":"G Cserni","year":"2018","unstructured":"Cserni, G., Chmielik, E., Cserni, B. & Tot, T. The new TNM-based staging of breast cancer. Virchows Arch. 472 (5), 697\u2013703 (2018).","journal-title":"Virchows Arch."},{"key":"23713_CR23","doi-asserted-by":"publisher","first-page":"3461694","DOI":"10.1155\/2024\/3461694","volume":"2024","author":"N Soltani Irdmusa","year":"2024","unstructured":"Soltani Irdmusa, N., Bashi Zadeh Fakhar, H., Heshmati, M., Akbari, M. E. & Rahimi, S. Comparison of BRCA1 gene expression and CA15-3 tumor marker level in different stages of breast cancer. Breast J. 2024, 3461694 (2024).","journal-title":"Breast J."},{"issue":"1","key":"23713_CR24","doi-asserted-by":"publisher","first-page":"113442","DOI":"10.1016\/j.yexcr.2022.113442","volume":"423","author":"MJ Kamali","year":"2023","unstructured":"Kamali, M. J. et al. Locked nucleic acid (LNA): A modern approach to cancer diagnosis and treatment. Exp. Cell. Res. 423 (1), 113442 (2023).","journal-title":"Exp. Cell. Res."},{"issue":"1","key":"23713_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40880-017-0226-3","volume":"36","author":"Y Gao","year":"2017","unstructured":"Gao, Y. et al. Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4\u00a0N\u2009+\u2009M0 gastric adenocarcinoma. Chin. J. Cancer. 36 (1), 61 (2017).","journal-title":"Chin. J. Cancer"},{"issue":"1","key":"23713_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3892\/mco.2023.2650","volume":"19","author":"N Rahadiani","year":"2023","unstructured":"Rahadiani, N., Stephanie, M., Perkasa, A. G., Handjari, D. R. & Krisnuhoni, E. p53 expression is associated with tumor stage, grade and subtype in patients with hepatocellular carcinoma. Mol. Clin. Oncol. 19 (1), 54 (2023).","journal-title":"Mol. Clin. Oncol."},{"issue":"4","key":"23713_CR27","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.3892\/ol.2017.6681","volume":"14","author":"Z Li","year":"2017","unstructured":"Li, Z., Han, C. & Feng, J. Relationship of the expression levels of XIAP and p53 genes in hepatocellular carcinoma and the prognosis of patients. Oncol. Lett. 14 (4), 4037\u20134042 (2017).","journal-title":"Oncol. Lett."},{"key":"23713_CR28","doi-asserted-by":"publisher","first-page":"154195","DOI":"10.1016\/j.prp.2022.154195","volume":"240","author":"F Li","year":"2022","unstructured":"Li, F. et al. To investigate the prognostic factors of stage \u2160-\u2161 gastric cancer based on P53 mutation and tumor budding. Pathol. Res. Pract. 240, 154195 (2022).","journal-title":"Pathol. Res. Pract."},{"key":"23713_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.humpath.2017.07.014","volume":"71","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer. Hum. Pathol. 71, 20\u201329 (2018).","journal-title":"Hum. Pathol."},{"issue":"1","key":"23713_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12957-022-02600-7","volume":"20","author":"C Xu","year":"2022","unstructured":"Xu, C. et al. Differential roles of the Wip1-p38-p53 DNA damage response pathway in early\/advanced-stage ovarian clear cell carcinomas. World J. Surg. Oncol. 20 (1), 139 (2022).","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"23713_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4103\/0971-5916.198685","volume":"144","author":"A Bansal","year":"2016","unstructured":"Bansal, A., Das, P., Kannan, S., Mahantshetty, U. & Mulherkar, R. Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancer patients in India. Indian J. Med. Res. 144 (3), 359\u2013365 (2016).","journal-title":"Indian J. Med. Res."},{"issue":"3","key":"23713_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12079-022-00697-9","volume":"17","author":"P Morovat","year":"2023","unstructured":"Morovat, P. et al. Survival-based bioinformatics analysis to identify hub long non-coding RNAs along with lncRNA-miRNA-mRNA network for potential diagnosis\/prognosis of thyroid cancer. J. Cell. Commun. Signal. 17 (3), 639\u2013655 (2023).","journal-title":"J. Cell. Commun. Signal."},{"issue":"1","key":"23713_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.canlet.2012.12.016","volume":"331","author":"NJ Nadkarni","year":"2013","unstructured":"Nadkarni, N. J. et al. Microvessel density and p53 mutations in advanced-stage epithelial ovarian cancer. Cancer Lett. 331 (1), 99\u2013104 (2013).","journal-title":"Cancer Lett."},{"issue":"3","key":"23713_CR34","doi-asserted-by":"publisher","first-page":"a026104","DOI":"10.1101\/cshperspect.a026104","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen, J. The Cell-Cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect. Med. 6 (3), a026104 (2016).","journal-title":"Cold Spring Harb Perspect. Med."},{"issue":"4","key":"23713_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4048\/jbc.2023.26.e30","volume":"26","author":"XY Lin","year":"2023","unstructured":"Lin, X. Y., Guo, L., Lin, X., Wang, Y. & Zhang, G. Concomitant PIK3CA and TP53 mutations in breast cancer: an analysis of clinicopathologic and mutational Features, neoadjuvant therapeutic Response, and prognosis. J. Breast Cancer. 26 (4), 363\u2013377 (2023).","journal-title":"J. Breast Cancer"},{"issue":"5","key":"23713_CR36","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/genes15050577","volume":"15","author":"R Khan","year":"2024","unstructured":"Khan, R., Pari, B. & Puszynski, K. Comprehensive bioinformatic investigation of TP53 dysregulation in diverse cancer landscapes. Genes 15 (5), 577 (2024).","journal-title":"Genes"},{"issue":"8","key":"23713_CR37","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1136\/jim-2018-000804","volume":"66","author":"L Calvocoressi","year":"2018","unstructured":"Calvocoressi, L. et al. Prostate cancer aggressiveness and age: impact of p53, BCL-2 and microvessel density. J. Investig Med. 66 (8), 1142\u20131146 (2018).","journal-title":"J. Investig Med."},{"issue":"8","key":"23713_CR38","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1158\/2159-8290.CD-13-0011","volume":"3","author":"Y Huo","year":"2013","unstructured":"Huo, Y. et al. Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer. Cancer Discov. 3 (8), 894\u2013907 (2013).","journal-title":"Cancer Discov"},{"issue":"11","key":"23713_CR39","doi-asserted-by":"publisher","first-page":"153186","DOI":"10.1016\/j.prp.2020.153186","volume":"216","author":"A Hodgson","year":"2020","unstructured":"Hodgson, A. et al. Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations. Pathol. Res. Pract. 216 (11), 153186 (2020).","journal-title":"Pathol. Res. Pract."},{"issue":"6","key":"23713_CR40","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.3802\/jgo.2019.30.e96","volume":"30","author":"T Ida","year":"2019","unstructured":"Ida, T., Fujiwara, H., Kiriu, T., Taniguchi, Y. & Kohyama, A. Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women. J. Gynecol. Oncol. 30 (6), e96 (2019).","journal-title":"J. Gynecol. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23713-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23713-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23713-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:40:18Z","timestamp":1763448018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23713-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23713"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23713-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Also, ethics committee of Azad University of Medical Sciences, Iran approved this study by (Code no: IR.IAU.PS.REC.1402.157).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors had given their consent for the publication of identifiable details, which can include photograph(s) and\/or videos and\/or case history and\/or details within the text (\u201cMaterial\u201d) to be published in the above Journal and Article. Therefore, anyone can read material published in the Journal.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"An informed consent was obtained from each individual participating in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"39894"}}